Prevalence and Prognostic Impact of Allelic Imbalances Associated with Leukemic Transformation of Philadelphia Chromosome-negative Myeloproliferative Neoplasms
Overview
Authors
Affiliations
Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) including polycythemia vera, essential thrombocythemia, and primary myelofibrosis show an inherent tendency for transformation into leukemia (MPN-blast phase), which is hypothesized to be accompanied by acquisition of additional genomic lesions. We, therefore, examined chromosomal abnormalities by high-resolution single nucleotide polymorphism (SNP) array in 88 MPN patients, as well as 71 cases with MPN-blast phase, and correlated these findings with their clinical parameters. Frequent genomic alterations were found in MPN after leukemic transformation with up to 3-fold more genomic changes per sample compared with samples in chronic phase (P < .001). We identified commonly altered regions involved in disease progression including not only established targets (ETV6, TP53, and RUNX1) but also new candidate genes on 7q, 16q, 19p, and 21q. Moreover, trisomy 8 or amplification of 8q24 (MYC) was almost exclusively detected in JAK2V617F(-) cases with MPN-blast phase. Remarkably, copy number-neutral loss of heterozygosity (CNN-LOH) on either 7q or 9p including homozygous JAK2V617F was related to decreased survival after leukemic transformation (P = .01 and P = .016, respectively). Our high-density SNP-array analysis of MPN genomes in the chronic compared with leukemic stage identified novel target genes and provided prognostic insights associated with the evolution to leukemia.
Myeloproliferative Neoplasms: Challenging Dogma.
Spivak J J Clin Med. 2024; 13(22).
PMID: 39598101 PMC: 11595126. DOI: 10.3390/jcm13226957.
Circulating CD133+/–CD34– Have Increased c- Expression in Myeloproliferative Neoplasms.
Uslu Bicak I, Tokcan B, Yavuz A, Tokdemir S Turk J Haematol. 2022; 40(1):28-36.
PMID: 36458557 PMC: 9979741. DOI: 10.4274/tjh.galenos.2022.2022.0343.
Genetic Background of Polycythemia Vera.
Regimbeau M, Mary R, Hermetet F, Girodon F Genes (Basel). 2022; 13(4).
PMID: 35456443 PMC: 9027017. DOI: 10.3390/genes13040637.
Wang X, Rampal R, Hu C, Tripodi J, Farnoud N, Petersen B JCI Insight. 2022; 7(8).
PMID: 35259128 PMC: 9089790. DOI: 10.1172/jci.insight.156534.
Brune M, Rau A, Overkamp M, Flaadt T, Bonzheim I, Schurch C Cancers (Basel). 2021; 13(22).
PMID: 34830756 PMC: 8615857. DOI: 10.3390/cancers13225605.